Skip to main content

Increasing Demand for Biopharmaceuticals Driving Growth In Aseptic Sampling Market

According to a new market research report "Aseptic Sampling Market by Type (Manual (Type (Traditional, Single use), Product (Bags, Bottles, Syringes, Accessories)), Automatic), Application (Upstream, Downstream), Technique (Off-line, On-line), End User (R&D, CMO) - Global Forecast to 2023", published by MarketsandMarkets™, the market is expected to grow at a CAGR of 13.5% from 2018 to 2023, to reach USD 1,247.0 million in 2023 from USD 662.1 million in 2018.

Browse 72 market data Tables and 26 Figures spread through 110 Pages and in-depth TOC on "Aseptic Sampling Market".

Ask for PDF Brochure @

https://www.marketsandmarkets.com/pdfdownload.asp?id=9034729

Based on application, the upstream processes segment is accounted for the largest share of the market in 2018

On the basis of application, the Aseptic Sampling Market is segmented into upstream process and downstream process. In 2018, the upstream process segment is expected to account for the largest share of the market. Being the start of bioproduction, upstream processes form a key application area for aseptic sampling. Any contamination originating from the upstream process will be carried to the following processes and affect overall production, leading to failure. Their importance in this stage is the key factor supporting the use of aseptic sampling products.

Based on type, the manual aseptic sampling segment is expected to account for the largest share of the market in 2018

On the basis of type, the Aseptic Sampling Market is categorized into manual aseptic sampling and automated aseptic sampling. In 2018, the manual aseptic sampling segment is expected to account for the largest share of the Aseptic Sampling Market. Manual Aseptic sampling is again divided into two segments traditional sampling type and single-use sampling type. In 2018, single-use sampling type is expected to account for the largest share in the manual Aseptic Sampling Market. Single-use aseptic sampling systems help drug manufacturers to mitigate cross-contamination and cost issues, leads to a high share in the market.

Ask for Sample Pages @
https://www.marketsandmarkets.com/requestsample.asp?id=9034729

Europe is expected to dominate the market in 2018

The Europe is expected to account for the largest share of the Aseptic Sampling Market in 2018. Government support for new biologics has encouraged the research and development of biologics. North America is accounted for the second-largest share of the market.

The major players operating in the market include Sartorius Stedim Biotech (
France), Merck Millipore (Germany), Danaher (US), and Thermo Fisher Scientific (US).

Objectives of the Study:
To define, describe, and forecast the aseptic sampling market by type, technique, application, end user, and region
To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and industry-specific challenges)
To strategically analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
To forecast the size of the market segments with respect to four main regions, namely, North America, Europe, Asia, and the Rest of the World (RoW)
To profile the key players and comprehensively analyze their product portfolios, market positions and core competencies
To track and analyze competitive developments such as acquisitions; collaborations and other such as webinar and product showcase in the aseptic/sterile sampling market

Comments

Popular posts from this blog

NGS-Based RNA-Sequencing Industry is Growing at a CAGR of 20%

NGS-based RNA-sequencing Market growth is driven mainly by the advantages of RNA-seq over conventional technologies; an increasing number of RNA-seq grants; rising number of research activities involving RNA-seq; and rapid growth in precision medicine market. NGS-based RNA-sequencing Market: Impact Analysis 1. NGS-Based RNA-Sequencing: Market Overview 2. Geographical Snapshot of the NGS-Based RNA-Sequencing Market 3. Rapid Growth in Precision Medicine 4. Growing Number of Research Activities Involving RNA-Seq 5. Increasing Applications of RNA-Seq in Research ( Cancer and Agricultural) The NGS-based RNA-sequencing market size is estimated to grow from USD 1.7 billion in 2019 to USD 4.2 billion by 2024, at a CAGR of 20.0%. Key Questions Addressed in The Report: 1. Who are the top 10 players operating in the global NGS-based RNA-sequencing market? 2. What are the drivers, restraints, opportunities, and challenges in the NGS-based RNA-sequencing Industry? 3. What are th...

Digital Diabetes Management Market to Reach $19.98 billion by 2024 | Market and Regional Growth Analysis

  Digital diabetes management solutions are smartphone-connected diabetes management devices and software platforms used by patients suffering from Type 1, Type 2, and gestational diabetes. Medical professionals also use these solutions to manage diabetes. Various digital diabetes management devices such as smart glucose meters, continuous glucose monitoring systems, smart insulin pens, and smart insulin pumps/closed-loop systems and smart insulin patches are used for glucose monitoring and insulin delivery. Diabetes management applications, data management software & platforms, and services are used by patients and healthcare providers for remote monitoring, data analysis, and disease management. The Digital Diabetes Management Market is experiencing significant growth due to rising prevalence of diabetes has increased the focus on the development and adoption of better solutions for diabetes care. Also, advancements in technologies have ensured the introduction of highly...

Epigenetics Market | Major Market Dynamics Impacting The Global Industry

Epigenetics refers to the covalent modification of DNA, RNA, or protein that results in changes to the function and/or regulation of these molecules, without altering their primary sequences. These modifications can occur naturally, or can be influenced, by several factors including age, environment, disease state, and changes in lifestyle. Expanding application areas of epigenetics in non-oncology diseases, personalized medicine, and target therapy are expected to provide growth opportunities for players operating in the epigenetics market in the coming years. The growth in this market is primarily attributed to decreasing sequencing costs, increasing research activity, funding for epigenetics research, rising prevalence of cancer and growing applications of epigenetics in non-oncology diseases. Epigenetic changes such as dysregulation of DNA methylation are associated with cancer development and progression. Epigenetics provides new opportunities for deriving therapeutic strateg...